
Nirspas Injection
Marketer
Nirlife Healthcare
Salt Composition
Dicyclomine (NA)
Overview Nirspas Injection
Abdominal pain and irritable bowel syndrome (IBS), characterized by abdominal discomfort, cramping, bloating, and altered bowel habits (diarrhea or constipation), are treated with Nirspas Injection. This injection alleviates sudden muscle spasms, thus reducing abdominal cramps. Administered by a healthcare professional, Nirspas Injection requires adherence to the prescribed treatment duration. Premature discontinuation may lead to symptom recurrence and condition exacerbation. Full disclosure of all other medications is crucial, as interactions are possible. Common, generally transient, side effects include dry mouth, blurred vision, nausea, fatigue, and anxiety. Report any concerning side effects immediately to your physician. Dizziness and drowsiness are potential effects; avoid driving or activities requiring alertness until the medication's impact is known. Alcohol consumption should be avoided due to potential additive drowsiness. Increased fluid intake is advised to mitigate potential diarrhea and prevent dehydration. Consult your doctor before using Nirspas Injection if pregnant, breastfeeding, or if you have liver or kidney disease, or a history of alcohol misuse. This injection is contraindicated in infants under six months.
Uses of Nirspas Injection
Chronic intestinal discomfort accompanied by stomach pain
Major Benefits of Nirspas Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Nirspas Injection:
- Nausea
- Dizziness
- Blurred vision
- Dryness in mouth
- Nervousness
- Drowsiness
- Vomiting
- Diarrhea
- Abdominal pain
- Confusion
- Hallucination
- Dry skin
How to use Nirspas Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Nirspas Injection works:
Nirspas Injection, an anticholinergic agent, alleviates gastrointestinal distress by diminishing muscle contractions in the stomach and intestines. This action suppresses spasms, providing relief from cramping, pain, distension, and general discomfort.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nirspas Injection and alcohol may lead to significant sedation.
PregnancyCONSULT YOUR DOCTOR
The use of Nirspas Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Administration of Nirspas Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Nirspas Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with impaired kidney function should use Nirspas Injection judiciously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Nirspas Injection judiciously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Nirspas Injection :
For a missed Nirspas Injection, administer the dose promptly. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Nirspas Injection
| Label | Value |
|---|---|
| Chemical Type | Trialkylamines |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
